Drug-related deaths and mortality in Europe: update from the EMCDDA expert network
Introduction
This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths. The meeting brought together experts and representatives from over 40 countries and provided a platform for discussing new trends in and analyses of drug-induced deaths in Europe and beyond and responses to them.
Download as PDF
Table of contents
- Acknowledgements
- Introduction to and aim of this report
- Overdose deaths in Europe: an overview
- Demographic characteristics of drug-related fatalities in Europe
- Heroin-related deaths in selected European countries
- Cocaine-related deaths in selected European countries
- Special focus: a European overview of deaths related to new psychoactive substances
- Fentanyl and fentanyl analogues
- Etizolam: concern around new benzodiazepines in Scotland
- Responding to drug-related deaths
- Drug consumption rooms
- Take-home naloxone programmes
- References